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Chondrosarcoma is a rare malignant tumor of bone. This family of tumors can be primary malignant tumors or a secondary
malignant transformation of an underlying benign cartilage tumor. Pain is often the initial presenting complaint when
chondrosarcoma involves the spine. In themobile spine, chondrosarcoma commonly presents within the vertebral body and shows
a predilection for the thoracic spine. Due to the resistance of chondrosarcoma to both radiation and chemotherapy, treatment is
focused on surgery. With en bloc excision of chondrosarcoma of the mobile spine and sacrum patients can have local recurrence
rates as low as 20%.
1. Introduction
Chondrosarcoma is a rare malignant bone tumor that
produces cartilage matrix. Chondrosarcoma can be subclas-
sified as a primary malignant bone tumor or a secondary
malignant transformation of an underlying enchondroma or
osteochondroma. The estimated annual incidence has been
reported as 1 in 200,000 [1]. The prevalence of chondrosar-
coma in the mobile spine is reported between 6.5 and 10%,
while approximately 5% are located within the sacrum [2–4].
Chondrosarcoma typically presents in patients between the
3rd and 7th decades.
2. Clinical Presentation
Patients with chondrosarcoma of the spine generally present
with pain in the area of the lesion. The pain is often insidious
in nature and can be present for weeks to years. Boriani et
al. noted a mass at presentation in 34% of patients in their
series [2], and Shives et al. reported 40% of patients with a
mass at presentation [3]. The neurologic presentation can be
somewhat mixed and can range from radicular pain to frank
weakness. Radicular symptoms are seen in roughly 24% of
patients [2, 5].
3. Location
Chondrosarcoma can occur within all regions of the spine.
Roughly 20% of chondrosarcoma arises in the cervical spine,
30% in the thoracic spine, 20% in the lumbar spine, and
20% in the sacrum. Several series have shown a higher
prevalence of chondrosarcoma in the thoracic spine. In the
MD Anderson experience, 48% (10/21), 33% (7/21), and
19% (4/21) were located in the thoracic, lumbar, and cervical
spines, respectively [5]. A similar breakdown was noted in
the series reported by Shives et al. [3]. Bergh et al. reported
on a series of 69 consecutive chondrosarcoma and found that
16% (11/69) were located in the sacrum [6].
Within the vertebra, Chondrosarcoma can be isolated
to the body, the posterior elements, or a combination of
both. Primary chondrosarcoma is predominately located in
the vertebral body, described as zones 10-3 according to the
WBB staging system [2, 3]. In contrast, chondrosarcoma
that arise from an underlying benign chondral lesion are
typically located in the posterior elements of the vertebra.
Sacral chondrosarcoma are typically located eccentrically in
the upper portion of the sacrum (Figures 1(a), 1(b), and







Figure 1: A 27-year-old female with a right sacroiliac secondary chondrosarcoma arising from a sacroiliac osteochondroma. The tumor
involved half of the sacrum, and a sagittal resection through the midline of the sacrum was required to obtain wide margins. She developed
scoliosis and sitting imbalance and underwent a subsequent posterior spinal fusion and instrumentation. She remains free of disease 48
months after surgery.
4. Staging
The appropriate staging of chondrosarcoma of the spine is
essential for prognosis and surgical treatment. Appropri-
ate staging includes radiologic and histologic information.
Imaging includes plain radiographs, CT scan, and MRI to
evaluate the tumor. Chondrosarcoma presents radiographi-
cally as a mixed lytic and blastic lesion. Low-grade lesions
have dense spicules of calcification and an eccentric, lobular
appearance. High-grade lesions can have amorphous areas
of calcifications and concentric growth of a soft tissue
component [8].
Additional imaging studies include a CT scan of the
chest, abdomen, and pelvis, as well as an MRI of the spine
to evaluate the rest of the spinal column. The appropriate
imaging studies allow for a better understanding of the extent
of the lesion as well as a diﬀerential diagnosis.
The histologic diagnosis is essential to the staging and
ultimate treatment of the spinal tumor. Prior excisional
biopsies can adversely aﬀect the treatment and survival of
patients with chondrosarcoma of the spine [9]. Thus a closed,
image-guided core needle biopsy with a trocar provides
a safe and eﬀective method of obtaining a histological
diagnosis in patients with suspected chondrosarcoma of the
spine. Histologic characteristics of chondrosarcoma include
chondroid matrix, mitotic figures, hypercellularity, nuclear
atypia, double-nucleated cells, and myxoid changes in the
stroma [3, 4, 8, 10].
Two systems are commonly used to stage primary tumors
of the spine. Enneking developed a system based on the
location of the tumor, the histologic grade of the lesion,
and whether metastases are present or not [11]. Low-
grade tumors are designated with the Roman numeral
(I) and high-grade lesions (II); if metastases are present,
the tumor is designated by the Roman numeral (III). In
addition the tumor is described as intracompartmental (A)
or extracompartmental (B). This classification system was
originally developed for tumors involving the appendicular
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skeleton and does have some limitations in the mobile spine.
Weinstein (WBB) proposed a classification and surgical
staging system developed specifically for spinal tumors [12].
The WBB staging system divides the vertebra into zones in
the axial plane in a radiating pattern similar to a clock face.
The numbers one through twelve designate the zones. The
second portion of this system classifies the tumor based on
layers designated by the letters A–E where (A) is prevertebral
extraosseous, (B) intraosseous superficial, (C) intraosseous
deep, (D) extraosseous extradural, and (E) extraosseous
intradural. TheWBB staging system then allows for direction
in the method of resection. If the tumor involves zones
4–8 or 5–9, a vertebrectomy with a double approach is
recommended, if zones 2–5 or 7–11 are involved, then a
sagittal resection is recommended, and if the tumor involves
zones 10-3, then a posterior arch resection is recommended.
5. Treatment
Chondrosarcoma are a family of slow-growing neoplasms. It
has been well established in the literature that these tumors
are resistant to chemotherapy and radiation therapy and thus
Chondrosarcoma is a surgical disease [2–7, 10, 13]. En bloc
or radical resection of chondrosarcoma involving the long
bones has led to 5-year survival rates as high as 54 to 78%
[4, 6, 10].
Surgical treatment consisting of either curettage or en
bloc resection has been described for both primary and
recurrent tumors [7, 13–16]. A description of the surgical
margin is important for comparing results and the prognosis
following surgical treatment. Intralesional excision refers to
tumor cells present on the surface of the resected tissue.
Marginal excision refers to a thin layer of tissue that is
reactive, but without neoplastic tissue. Wide excision refers
to a tumor-free cuﬀ of normal tissue surrounding the lesion.
In the mobile spine and sacrum, the inherent intimate
relationship of the neurovascular structures and need for
structural stabilization can make en bloc resection diﬃcult,
and in some cases intralesional curettage ismore appropriate.
Boriani et al. proposed a set of criteria directing treatment
toward curretage. These criteria include circumferential
spinal canal involvement, the need for spinal cord ligation to
complete en bloc resection, and the potential for spinal cord
ischemia from ligation of the spinal segmental artery [2].
Unfortunately, results following curretage are poor. In
their series of twenty-two patients with chondrosarcoma of
the mobile spine, Boriani et al. reported at least one local
recurrence or progression of disease in 100% of patients
(10/10) treated with curretage. 80% of these patients died at
a mean of thirty-six months [2]. In contrast, 25% (3/12) of
patients treated with en bloc marginal resection had a local
recurrence. The margins were classified as contaminated
or intralesional in two of the three patients with local
recurrence after en bloc excision. Shives et al. reported
on twenty patients with chondrosarcoma of the mobile
spine. Similar to the previously cited study, 100% (11/11) of
patients treated with intralesional excision had documented
disease progression at a mean of 24.8 months. All of the
patients treated with an intralesional excision died [3].
York et al. found a 69% recurrence rate in patients treated
intralesionally with a subtotal excision at a mean of 44.4
months compared to a 20% recurrence rate in those treated
with en bloc resection [5].
The role of en bloc resection in the treatment of
chondrosarcoma of the sacrum has also been well established
[7, 13]. Fourney et al. reported on three patients with
chondrosarcoma in their series on en bloc resection of sacral
tumors. All three patients had local recurrence, but it is
important to note that all three patients had previously
undergone a subtotal excision prior to their planned en bloc
resection [7]. This further supports the important role of
negative margins and en bloc resection in the successful
treatment of chondrosarcoma involving the spine.
Although en bloc resection can improve the clinical
results of the surgical treatment of chondrosarcoma, the
procedures do not come without complications. In a review
of 134 patients who underwent en bloc resection at a single
institution, complications were noted in 48 patients. A total
of 43 major complications were noted in 27 patients, and
29 minor complications were noted in 28 patients. Major
complications included vascular injuries to the vena cava and
aorta, myocardial infarction, pulmonary embolism, deep
infection requiring surgical debridement, transient renal
failure, ureteral injury, temporary paraplegia, and an ex
vacuo cerebral hematoma secondary to cerebrospinal fluid
leak. Three patients died from complications related to the
procedure [17].
6. Conclusion
Chondrosarcoma is a malignancy of bone that can present
within the mobile spine and the sacrum. The eﬀective staging
of chondrosarcoma plays an essential role in the disease
treatment. This family of tumors is known to be resistant to
both chemotherapy and radiation therapy, thus treatment is
directed toward surgery. The prognosis of chondrosarcoma
involving the spine is related to the histological grade of the
tumor, the age of the patient at the time of diagnosis, initial
treatment taking place in a primary tumor center, and most
importantly the adequacy of the surgical margins. Patients
who undergo successful en bloc excision have recurrence
rates as low as 20%.
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